Related references
Note: Only part of the references are listed.Proapoptotic Effect and Molecular Docking Analysis of Curcumin-Resveratrol Hybrids in Colorectal Cancer Chemoprevention
Gustavo Moreno-Q et al.
MOLECULES (2022)
Colorectal Cancer Chemoprevention by S-Allyl Cysteine-Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies
Angie Herrera-Ramirez et al.
SCIENTIA PHARMACEUTICA (2022)
Coffee in cancer chemoprevention: an updated review
Tariq Ismail et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Chemistry andn Anticancer Activity of Hybrid Molecules and Derivaties based on n5-Fluorouracil
Wilson Cardona-G et al.
CURRENT MEDICINAL CHEMISTRY (2021)
New Hybrids Based on Curcumin and Resveratrol: Synthesis, Cytotoxicity and Antiproliferative Activity against Colorectal Cancer Cells
Cristian Hernandez et al.
MOLECULES (2021)
Management of colorectal cancer in the era of COVID-19: Challenges and suggestions
Walid Alam et al.
SCIENCE PROGRESS (2021)
Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs
Mohamed Salla et al.
MOLECULES (2020)
Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
Rodney Hull et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Anti-cancer effect of Indanone-based thiazolyl hydrazone derivative on colon cancer cell lines
Silpa Narayanan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Discovery of novel indole-based aroylhydrazones as anticonvulsants: Pharmacophore-based design
Violina T. Angelova et al.
BIOORGANIC CHEMISTRY (2019)
Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease
Wilson Cardona-G et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Potent hydrazone derivatives targeting esophageal cancer cells
Ling-Yu Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Natural compounds and combination therapy in colorectal cancer treatment
A. Rejhova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and antiproliferative activity of 3-and 7-styrylcoumarins
Angie Herrera-R et al.
MEDICINAL CHEMISTRY RESEARCH (2018)
Synthetic resveratrol-curcumin hybrid derivative inhibits mitosis progression in estrogen positive MCF-7 breast cancer cells
Matheus de Freitas Silva et al.
TOXICOLOGY IN VITRO (2018)
Impairing Powerhouse in Colon Cancer Cells by Hydrazide-Hydrazone-Based Small Molecule
Sohan Patil et al.
ACS OMEGA (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Recent advances (2015-2016) in anticancer hybrids
Nagaraju Kerru et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, antiprotozoal activity and cytotoxicity in U-937 macrophages of triclosan-hydrazone hybrids
Sebastian Vergara et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
The fermented non-digestible fraction of spent coffee grounds induces apoptosis in human colon cancer cells (SW480)
Nataly Garcia-Gutierrez et al.
JOURNAL OF FUNCTIONAL FOODS (2017)
Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect.
Thomas Sithara et al.
FRONTIERS IN PHARMACOLOGY (2017)
Synthesis of 2,5-Disubstituted-1,3,4-oxadiazole Derivatives and Their Evaluation as Anticancer and Antimycobacterial Agents
Naveen Polkam et al.
CHEMISTRYSELECT (2017)
Synthesis and biological evaluation of indole derivatives as α-amylase inhibitor
Syahrul Imran et al.
BIOORGANIC CHEMISTRY (2017)
Recent advances in cancer treatment by iron chelators
Vincent Corce et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α-glucosidase inhibitory activity, and molecular modeling studies
Uzma Salar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
Dona Sinha et al.
SEMINARS IN CANCER BIOLOGY (2016)
Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids
Juan Carlos Coa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-tumor effects and cellular mechanisms of resveratrol
Guohua Han et al.
DRUG DISCOVERIES AND THERAPEUTICS (2015)
Novel arylhydrazone derivatives bearing a rhodanine moiety: synthesis and evaluation of their antibacterial activities
Wei Li et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
Inhibition of Cancer Derived Cell Lines Proliferation by Synthesized Hydroxylated Stilbenes and New Ferrocenyl-Stilbene Analogs. Comparison with Resveratrol
Malik Chalal et al.
MOLECULES (2014)
Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents
H. S. Naveen Kumar et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
A review exploring biological activities of hydrazones
Garima Verma et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
Cancer chemoprevention: a rapidly evolving field
W. P. Steward et al.
BRITISH JOURNAL OF CANCER (2013)
Iron Chelators for the Treatment of Cancer
Y. Yu et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Design, Synthesis, and Pharmacological Evaluation of N-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors
Arthur E. Kuemmerle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents
Ban-Feng Ruan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo
Yu Bai et al.
CANCER SCIENCE (2010)
Recent Progress in the Development of Synthetic Hybrids of Natural or Unnatural Bioactive Compounds for Medicinal Chemistry
Svetlana B. Tsogoeva
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells
Andre Wirries et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2010)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Modulation by polyamines of apoptotic pathways triggered by procyanidins in human metastatic SW620 cells
M. E. Maldonado-Celis et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
Preetha Anand et al.
PHARMACEUTICAL RESEARCH (2008)
Resveratrol: A review of preclinical studies for human cancer prevention
Mohammad Athar et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Biological activities of hydrazone derivatives
Sevim Rollas et al.
MOLECULES (2007)
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Sharmila Shankar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Bioactivity of resveratrol
Robert E. King et al.
COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2006)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse
M Mahyar-Roemer et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis
Y Schneider et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)